Skip to main content

Table 1 Gemcitabine and docetaxel in advanced osteosarcoma

From: Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Drugs Pts n. RR CR/PR Authors
G 1,000 mg/m2 7 0 % 0/0 Merimsky O, Sarcoma 2000 [13]
G 675 mg/m2 D 75–100 mg/m2 10 30 % 0/3 Navid F, Cancer 2008 [14]
G 900 mg/m2 D 80–100 mg/m2 14 7 % 0/1 Fox E. SARC 003, Oncologist 2010 [15]
G 675 mg/m2 ± D 75–100 mg/m2 4 25 % 0/1 Gosiengfiao Y, J Pediatr Hematol Oncol 2012 [16]
G 675 mg/m2 + D 75–100 mg/m2 18 5 % 0/1 Qi WX, Jpn J Clin Oncol 2012 [17]
G 675–900 mg/m2 D 100 mg/m2 17 24 % 3/1 Song BS, Pediatr Blood Cancer 2014 [18]
  1. GD gemcitabine and docetaxel, RR response rate, CR complete response, PR partial response